Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:36 PM
Ignite Modification Date:
2025-12-24 @ 4:36 PM
NCT ID:
NCT02251366
Eligibility Criteria:
Inclusion criteria:
* Established diagnosis of NVAMD in one or both eyes
* Received 2 or more intravitreal injections of anti-VEGF therapy from the retinal physician during the prior 6 months
* Need for more therapy on a near monthly basis is anticipated
* Usual corrected visual acuity (UCVA) of at least one eye must be 20/200 or better
* Must be physically able to cooperate with OCT and other diagnostic imaging procedures
* Must be able to give informed consent and be able to complete telephone surveys
Exclusion criteria:
* Systemic disease that can affect the peripheral retina (e.g., diabetes mellitus, sickle cell)
* History of symptomatic posterior vitreous detachment, retinal tear, or retinal detachment
* History of retinal surgery will not be enrolled.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
100 Years
Study:
NCT02251366
Study Brief:
Protocol Section:
NCT02251366